Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions.

Gastroenterology Res · 2022 · PMC8913022 · PMID 35369681

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

As for the risk reduction in HCC development with statin use, this was borderline significant for cirrhosis secondary to chronic HCV but not for cirrhosis secondary to chronic HBV infection or alcohol use disorder [ 67 ].

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.